Oppenheimer & Co. Inc. boosted its holdings in shares of Nutrien Ltd. (NYSE:NTR - Free Report) by 300.7% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 26,885 shares of the company's stock after buying an additional 20,175 shares during the quarter. Oppenheimer & Co. Inc.'s holdings in Nutrien were worth $1,203,000 at the end of the most recent reporting period.
A number of other institutional investors also recently bought and sold shares of NTR. HHM Wealth Advisors LLC grew its stake in shares of Nutrien by 331.0% during the 4th quarter. HHM Wealth Advisors LLC now owns 625 shares of the company's stock worth $28,000 after purchasing an additional 480 shares during the period. Asset Planning Inc acquired a new stake in shares of Nutrien during the 4th quarter worth approximately $35,000. Exchange Traded Concepts LLC grew its stake in shares of Nutrien by 96.7% during the 4th quarter. Exchange Traded Concepts LLC now owns 846 shares of the company's stock worth $38,000 after purchasing an additional 416 shares during the period. Principal Securities Inc. grew its stake in shares of Nutrien by 138.1% during the 4th quarter. Principal Securities Inc. now owns 931 shares of the company's stock worth $42,000 after purchasing an additional 540 shares during the period. Finally, Union Bancaire Privee UBP SA acquired a new stake in shares of Nutrien during the 4th quarter worth approximately $67,000. 63.10% of the stock is owned by hedge funds and other institutional investors.
Nutrien Trading Down 0.2 %
Shares of NYSE NTR traded down $0.12 during trading on Friday, hitting $51.03. 2,899,943 shares of the company were exchanged, compared to its average volume of 1,982,798. Nutrien Ltd. has a 12-month low of $43.70 and a 12-month high of $60.87. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.82 and a current ratio of 1.27. The company has a fifty day moving average price of $50.71 and a 200-day moving average price of $48.57. The firm has a market capitalization of $24.96 billion, a PE ratio of 37.24, a P/E/G ratio of 1.19 and a beta of 0.81.
Nutrien (NYSE:NTR - Get Free Report) last posted its quarterly earnings results on Wednesday, February 19th. The company reported $0.28 EPS for the quarter, missing the consensus estimate of $0.37 by ($0.09). Nutrien had a return on equity of 6.81% and a net margin of 2.62%. The company had revenue of $5.08 billion for the quarter, compared to analysts' expectations of $5.09 billion. As a group, equities research analysts expect that Nutrien Ltd. will post 3.72 EPS for the current year.
Nutrien Cuts Dividend
The business also recently declared a quarterly dividend, which will be paid on Thursday, April 10th. Stockholders of record on Monday, March 31st will be issued a dividend of $0.545 per share. The ex-dividend date of this dividend is Monday, March 31st. This represents a $2.18 annualized dividend and a dividend yield of 4.27%. Nutrien's dividend payout ratio is presently 159.12%.
Wall Street Analysts Forecast Growth
A number of research firms recently issued reports on NTR. Mizuho lifted their price target on shares of Nutrien from $52.00 to $55.00 and gave the company a "neutral" rating in a research note on Thursday, February 20th. Royal Bank of Canada reissued an "outperform" rating and issued a $60.00 price target on shares of Nutrien in a research note on Monday, February 24th. Scotiabank lifted their price target on shares of Nutrien from $60.00 to $62.00 and gave the company a "sector outperform" rating in a research note on Monday, February 24th. CIBC lifted their price target on shares of Nutrien from $64.00 to $66.00 and gave the company an "outperformer" rating in a research note on Tuesday, February 25th. Finally, Raymond James raised shares of Nutrien from a "market perform" rating to an "outperform" rating and lifted their price target for the company from $58.00 to $60.00 in a research note on Tuesday, December 3rd. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat, Nutrien currently has an average rating of "Moderate Buy" and an average target price of $59.94.
Get Our Latest Stock Report on NTR
Nutrien Profile
(
Free Report)
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.
See Also
Before you consider Nutrien, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.
While Nutrien currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
